摘要:
Aspects describe a separate domain selection function that is utilized as the first function in a communication path for a communication that is to be connected to a user device registered in a first network or a second network. If a result of the domain selection function indicates call control should be maintained by first network (e.g., user device is registered with first network or a network with which first network has a control relationship), call control of the communication remains with first network. If the result of the domain selection function indicates the user device is registered with second network, call control is suspended by the first network, which allows the communication to bypass the first network.
摘要:
Aspects describe a separate domain selection function that is utilized as the first function in a communication path for a communication that is to be connected to a user device registered in a first network or a second network. If a result of the domain selection function indicates call control should be maintained by first network (e.g., user device is registered with first network or a network with which first network has a control relationship), call control of the communication remains with first network. If the result of the domain selection function indicates the user device is registered with second network, call control is suspended by the first network, which allows the communication to bypass the first network.
摘要:
A method and system are adapted to provide telephony services to aggregate endpoints on an Internet Protocol Multimedia Subsystem (IMS) network. The method includes assigning one or multiple PUIDs for surrogate registration purposes during the provisioning of the aggregate endpoint, performing reliable surrogate registration on behalf of the aggregate endpoint, allowing multiple SBCs to perform surrogate registrations independently for the same aggregate endpoint to achieve reliability, and providing reliable connection from an IMS core to the aggregate endpoints via multiple S/BCs. The system includes one or more Session Border Controllers (S/BC), at least one set of Call/Session Control Functions (CSCF), and an HSS operatively coupled together.
摘要:
Many of the current IMS standards and enriched services were originally designed for the individual subscribers that are serviced by the wireless network. However, the IMS standards do not fully address the problem of providing the IMS enriched services and features to business PBX customers or wholesale customers that do not directly register to the IMS network. The present invention discloses a method for providing IMS enriched services and features to business PBX customers or wholesale customers through the use of a static provisioning and registration method.
摘要:
Many of the current IMS standards and enriched services were originally designed for the individual subscribers that are serviced by the wireless network. However, the IMS standards do not fully address the problem of providing the IMS enriched services and features to business PBX customers or wholesale customers that do not directly register to the IMS network. The present invention discloses a method for providing IMS enriched services and features to business PBX customers or wholesale customers through the use of a static provisioning and registration method.
摘要:
Many of the current IMS standards and enriched services were originally designed for the individual subscribers that are serviced by the wireless network. However, the IMS standards do not fully address the problem of providing the IMS enriched services and features to users connected to a PBX. The present invention discloses a method for providing IMS enriched services and features to users connected to a PBX or an IP-PBX. Access to network services can be secured through a web-friendly interface via the IMS, enabling third-party developers, service providers and even subscribers to self-manage their service experience while the network operator retains control over network resources.
摘要:
Many of the current IMS standards and enriched services were originally designed for the individual subscribers that are serviced by the wireless network. However, the IMS standards do not fully address the problem of providing the IMS enriched services and features to users connected to a PBX. The present invention discloses a method for providing IMS enriched services and features to users connected to a PBX or an IP-PBX. Access to network services can be secured through a web-friendly interface via the IMS, enabling third-party developers, service providers and even subscribers to self-manage their service experience while the network operator retains control over network resources.
摘要:
A method and system are adapted to provide telephony services to aggregate endpoints on an Internet Protocol Multimedia Subsystem (IMS) network. The method includes assigning one or multiple PUIDs for surrogate registration purposes during the provisioning of the aggregate endpoint, performing reliable surrogate registration on behalf of the aggregate endpoint, allowing multiple SBCs to perform surrogate registrations independently for the same aggregate endpoint to achieve reliability, and providing reliable connection from an IMS core to the aggregate endpoints via multiple S/BCs. The system includes one or more Session Border Controllers (S/BC), at least one set of Call/Session Control Functions (CSCF), and an HSS operatively coupled together.
摘要:
A class of polycyclic compounds of general formula (I), wherein Base1, Base2, Y, Za, Xa, Xa1, Xb, Xb1, Xc, Xc1, Xd, Xd1, R1, R1a, R2, R2a, R3, R4, R4a, R5, R6, R6a, R7, R7a, R8, R8a, and R9 are defined herein, that may be useful as inductors of type I interferon production, specifically as STING active agents, are provided. Also provided are processes for the synthesis and use of compounds.
摘要:
The present invention is directed to substituted certain 1-pyrazolyl, 5-, 6-disubstituted indazole derivatives of Formula (I) and pharmaceutically acceptable salts thereof, wherein R1, R2, and ring A are as defined herein, which are potent inhibitors of LRRK2 kinase and may be useful in the treatment or prevention of diseases in which the LRRK2 kinase is involved, such as Parkinson's Disease and other diseases and disorders described herein. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of diseases, such as Parkinson's disease, in which LRRK-2 kinase is involved.